Compare iShares TIPS Bond ETF (TIP) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares TIPS Bond ETF vs State Street SPDR S&P Biotech ETF — how do they compare? iShares TIPS Bond ETF trades at $106.93, while State Street SPDR S&P Biotech ETF trades at $159.11. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, iShares TIPS Bond ETF nearer its low. Which is the better fit depends on your goals.
| TIP | XBI | |
|---|---|---|
Sector | Fixed Income | Broad Market / Factor |
52-Week High | $112.20 | $164.28 |
52-Week Low | $106.86 | $86.92 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TIP trades at $106.95 with minimal daily movement (+0.08%). Technical indicators show a bearish trend with moving averages signaling sell pressure, though oscillators are neutral. The company has announced three upcoming dividends totaling $3.12 per share through mid-2026. Recent financial ratios are unavailable, limiting fundamental assessment. Market sentiment is dominated by broader bond market concerns and inflation expectations.
The outlook remains cautious due to technical weakness and limited fundamental visibility. Dividend payments provide income appeal, but the bearish technical setup and macroeconomic uncertainty around interest rates pose near-term risks. Investors should await updated financial disclosures for clearer valuation metrics.
XBI trades at $158.81, up 0.49% today, with a bullish technical signal supported by moving averages. The ETF shows strong momentum with a 17% monthly gain and 75% annual return, driven by biotech sector strength. Analyst coverage is limited to one hold rating, while recent news highlights institutional buying interest and positive sector developments including M&A activity and drug trial successes.
The outlook remains positive given biotech's breakout from multi-year bear markets, though elevated volatility and policy risks persist. Key opportunities include AI-driven drug discovery and sustained M&A momentum, while risks involve sector-specific volatility and regulatory uncertainty. The ETF's equal-weight approach provides diversified exposure to biotech innovation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares TIPS Bond ETF
TIP is the flagship ETF for U.S. Treasury Inflation-Protected Securities (TIPS). It tracks an index of government bonds whose principal value adjusts based on the Consumer Price Index (CPI), providing a direct hedge against rising inflation.
Read more on TIP →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
